Marine Anti-inflammatory Agents 2024
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: 31 January 2025 | Viewed by 60
Special Issue Editor
Special Issue Information
Dear Colleagues,
I am pleased to inform you that I am organising a Special Issue titled “Marine Anti-inflammatory Agents 2024” in /Marine Drugs/ (ISSN: 1660-3397, https://www.mdpi.com/journal/marinedrugs). Given your distinguished expertise in this area, I warmly invite you to submit articles, short communications, or letters to this Special Issue.
Below is a brief introduction to the focus we are seeking for this Special Issue:
Inflammation, while a crucial biological response for body defence, can become dysregulated and lead to various chronic diseases. Effectively addressing inflammation is essential for improving the quality of life and preventing health complications. Marine-derived anti-inflammatory compounds are particularly valuable due to their diverse and unique chemical composition, offering new therapeutic perspectives.
Marine anti-inflammatory agents are emerging as innovative sources of new treatments. For instance, sulphated polysaccharides have shown significant effects in reducing inflammation and pain, opening new therapeutic possibilities by modulating inflammatory pathways involved in cytokine production and leukocyte migration. Likewise, cyclic peptides can effectively inhibit mast cell degranulation and the generation of inflammatory cells, showing tremendous potential in treating allergic and inflammatory diseases by modulating the release of mediators such as histamine and cytokines. Furthermore, compounds like diterpenoids and sesquiterpenoids have demonstrated significant anti-inflammatory properties by targeting enzymes involved in inflammatory processes, such as cyclooxygenases and lipoxygenases. Amino acids, such as mycosporines, have shown anti-inflammatory activity in human keratinocytes, suggesting promising applications in dermatological products by modulating inflammation induced by UV radiation and oxidative stress.
Moreover, marine lipid bioactives, such as omega-3 fatty acids, have shown significant anti-inflammatory effects by influencing the synthesis of inflammatory mediators and modulating immune responses. These compounds offer additional benefits due to their ability to integrate into cell membranes and alter inflammatory signalling cascades.
Finally, patented marine extracts like Lyprinol have demonstrated efficacy in reducing inflammation and osteoarthritis symptoms in clinical trials by targeting multiple pathways, including prostaglandin synthesis and leukotriene production. All these advancements have been made possible through advanced screening techniques that have identified new marine compounds with anti-inflammatory properties, opening new avenues for the development of innovative therapies. The application of OMIC technologies, such as lipidomics, proteomics, genomics, and metabolomics, along with structural analysis and the elucidation of structure–activity relationships, has provided a deeper understanding of how these marine compounds interact with biological systems and how they can be optimised for therapeutic applications
This field represents unexplored potential and a rich source of opportunities for researchers interested in discovering and developing new therapies based on marine natural products. We invite you to contribute your research and discoveries in this exciting and promising area of science.
Dr. Luis Apaza Ticona
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anti-inflammatory
- marine compounds
- sulphated polysaccharides
- lipid bioactives
- OMIC technologies
